Alhajj Nasser, Naharudin Idanawati, Colombo Paolo, Quarta Eride, Wong Tin Wui
Non-Destructive Biomedical and Pharmaceutical Research Centre, Smart Manufacturing Research Institute, Universiti Teknologi MARA Selangor, Puncak Alam 42300, Selangor, Malaysia.
Particle Design Research Group, Faculty of Pharmacy, Universiti Teknologi MARA Selangor, Puncak Alam 42300, Selangor, Malaysia.
Pharmaceutics. 2021 Sep 29;13(10):1581. doi: 10.3390/pharmaceutics13101581.
Pulmonary delivery of chitosan nanoparticles is met with nanoparticle agglomeration and exhalation. Admixing lactose-based microparticles (surface area-weighted diameter~5 μm) with nanoparticles mutually reduces particle agglomeration through surface adsorption phenomenon. Lactose-polyethylene glycol (PEG) microparticles with different sizes, morphologies and crystallinities were prepared by a spray drying method using varying PEG molecular weights and ethanol contents. The chitosan nanoparticles were similarly prepared. In vitro inhalation performance and peripheral lung deposition of chitosan nanoparticles were enhanced through co-blending with larger lactose-PEG microparticles with reduced specific surface area. These microparticles had reduced inter-microparticle interaction, thereby promoting microparticle-nanoparticle interaction and facilitating nanoparticles flow into peripheral lung.
壳聚糖纳米颗粒的肺部给药会遇到纳米颗粒团聚和呼出问题。将基于乳糖的微粒(表面积加权直径约5μm)与纳米颗粒混合,通过表面吸附现象可相互减少颗粒团聚。使用不同的聚乙二醇(PEG)分子量和乙醇含量,通过喷雾干燥法制备了具有不同尺寸、形态和结晶度的乳糖-PEG微粒。壳聚糖纳米颗粒的制备方法类似。通过与比表面积减小的较大乳糖-PEG微粒共混,壳聚糖纳米颗粒的体外吸入性能和外周肺沉积得到了增强。这些微粒间的微粒相互作用减少,从而促进了微粒-纳米颗粒相互作用,并有助于纳米颗粒流入外周肺。